Skip to main content

Phillippe Aumont pitches in the bottom of first inning during the WBSC Premier 12 Opening Game Group C game between Cuba and Canada at the Gocheok Sky Dome on Nov. 6, 2019, in Seoul.

Chung Sung-Jun/Getty Images

Pitchers Phillippe Aumont, A.J. Cole and Justin Miller headline a handful of free agents the Blue Jays signed to minor-league contracts on Monday with invitations to Toronto’s Major League spring training.

The Blue Jays also signed second baseman Andy Burns and outfielder Patrick Kivlehan.

Aumont, a 30-year-old right-hander from Gatineau spent last season with the Ottawa Champions of the independent Can-Am League. He made 18 starts and finished with an 8-4 record and a 2.65 earned-run average, while also recording six complete games and 145 strikeouts over 118 2/3 innings of work. He played for the Philadelphia Phillies from 2012-15.

Story continues below advertisement

The 27-year-old Cole had a 3.81 ERA while making 25 appearances for the Cleveland Indians last season. The 6-foot-5, 238-pound, right-handed pitcher struck out 30 batters and issued eight walks in 26 innings of work before being placed on the injured list with a right shoulder impingement from Aug. 10 through the end of the season.

Miller, 32, posted a 4.02 ERA across 15.2 innings pitched for the Washington Nationals last season. The righty has spent five seasons in the major leagues, having also pitched for the Detroit Tigers and Colorado Rockies compiling a 4.43 ERA, a 1.26 WHIP, 54 walks and 159 strikeouts over 156.1 innings.

The 29-year-old Burns hit .275 with 17 doubles, three triples, 19 home runs and 63 runs batted in across 118 games for triple-A Buffalo last season. He was selected by Toronto in the 11th round of the 2011 First-Year Player Draft and played 10 games for the Blue Jays in 2016.

Kivlehan, 29, played 90 games for Buffalo last season, hitting .247 with 13 doubles, three triples and 25 home runs. He also played for triple-A Indianapolis and double-A New Hampshire in 2019.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies